Maybank IB Research keeps Buy calls on KPJ, Kossan

For KPJ, Maybank Investment Bank Research projects EPS growth of 4% in FY20E and 10% in FY21E, underpinned by its fast bed capacity growth of 8% in FY20E (FY19E: +3%).

KUALA LUMPUR: Maybank Investment Bank Research has Buy calls on KPJ Healthcare and Kossan in the healthcare segment.

It said on Tuesday that for KPJ, it projects EPS growth of 4% in FY20E and 10% in FY21E, underpinned by its fast bed capacity growth of 8% in FY20E (FY19E: +3%).